{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:17:48Z","timestamp":1787743068607,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Vaginal intraepithelial neoplasia (VaIN) is a\u00a0rare condition that poses diagnostic and management challenges and carries a\u00a0significant risk of progression to invasive cancer. Image-guided interventional radiotherapy (IG-IRT, modern brachytherapy) has a\u00a0high overall success rate, but it is usually reserved for poor surgical candidates and those with multifocal disease or failed prior treatments. This study evaluates the efficacy and safety of IG-IRT in high-grade VaIN by combining a\u00a0retrospective institutional case series with a\u00a0systematic review of the available literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed patients with VaIN3 who received IG-IRT with curative intent between January 2019 and May 2025. The OncentraBrachy treatment planning system and a\u00a0Flexitron (Elekta, Stockholm, Sweden) afterloading machine with a\u00a0192-Ir source were used for IG-IRT. The IG-IRT total dose was 40\u202fGy over eight high-dose-rate (HDR) fractions to achieve 60\u202fGy equivalent dose in 2\u2011Gy fractions (EQD2\u03b1\/\u03b210) to the clinical target volume (CTV). The exact vaginal target was decided based on the site and the number of lesions. Primary study endpoint was local control (LC); secondary endpoints included the rate and severity of acute and late treatment-related toxicity. A\u00a0systematic review of the literature was conducted according to the PRISMA guidelines to contextualize institutional outcomes within the existing evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A\u00a0total of 10\u00a0patients with high-grade VaIN who were na\u00efve to prior radiotherapy were included in this study. The median follow-up duration was 17\u00a0months (7\u201370\u00a0months). The 1\u2011year actuarial LC and overall survival (OS) rates were 100%. No acute side effects were recorded, while late G2 toxicity (vaginal stenosis\u00a01 and atrophy\u00a04) occurred in four patients. Findings from the systematic review were consistent with the institutional results, supporting high rates of local control and an acceptable toxicity profile with IG-IRT in selected patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By integrating institutional experience with a\u00a0systematic review of the literature, this study supports IG-IRT as an effective and safe definitive treatment option for high-grade VaIN, achieving excellent LC with acceptable toxicity. This combined approach provides a\u00a0more robust framework for clinical decision-making in a\u00a0rare disease setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-026-02549-6","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:36:24Z","timestamp":1779806184000},"page":"976-985","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Image-guided interventional radiotherapy (modern brachytherapy) for treatment of vaginal intraepithelial neoplasia: single-institution experience and systematic literature review and meta-analysis"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-7051","authenticated-orcid":false,"given":"V.","family":"Lancellotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Solazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fionda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Garganese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Fragomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"La Milia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dragonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Laurino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"De Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Iezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"4","key":"2549_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/ijgc-2022-004213","volume":"33","author":"V Kesic","year":"2023","unstructured":"Kesic\u00a0V, Carcopino\u00a0X, Preti\u00a0M et\u00a0al (2023) ESGO\/ISSVD\/ECSVD\/EFC consensus statement on the management of vaginal intraepithelial neoplasia. Int J Gynecol Cancer 33(4):446\u2013461. https:\/\/doi.org\/10.1136\/ijgc-2022-004213","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2549_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/gyno.2001.6395","volume":"83","author":"JE Dodge","year":"2001","unstructured":"Dodge\u00a0JE, Eltabbakh\u00a0GH, Mount\u00a0SL, Walker\u00a0RP, Morgan\u00a0A (2001) Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol 83(2):363\u2013369. https:\/\/doi.org\/10.1006\/gyno.2001.6395","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2549_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0029-7844(96)00473-4","volume":"89","author":"FH Sillman","year":"1997","unstructured":"Sillman\u00a0FH, Fruchter\u00a0RG, Chen\u00a0YS et\u00a0al (1997) Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion. Obstet Gynecol 89(3):384\u2013388. https:\/\/doi.org\/10.1016\/S0029-7844(96)00473-4","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2549_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/gyno.2000.5937","volume":"79","author":"EA Joura","year":"2000","unstructured":"Joura\u00a0EA, L\u00f6sch\u00a0A, Haider-Angeler\u00a0MG, Breitenecker\u00a0G, Leodolter\u00a0S (2000) Topical imiquimod therapy for vaginal intraepithelial neoplasia. Gynecol Oncol 79(1):133\u2013136. https:\/\/doi.org\/10.1006\/gyno.2000.5937","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2549_CR5","first-page":"29","volume":"33","author":"A Frega","year":"2013","unstructured":"Frega\u00a0A, Sopracordevole\u00a0F, Assorgi\u00a0C et\u00a0al (2013) Vaginal intraepithelial neoplasia: a therapeutic dilemma. Anticancer Res 33(1):29\u201338","journal-title":"Anticancer Res"},{"issue":"2","key":"2549_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1067\/mob.2001.116282","volume":"185","author":"RJ Cardosi","year":"2001","unstructured":"Cardosi\u00a0RJ, Bomalaski\u00a0JJ, Hoffman\u00a0MS (2001) Diagnosis and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol 185(2):435\u2013443. https:\/\/doi.org\/10.1067\/mob.2001.116282","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2549_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"R P\u00f6tter","year":"2006","unstructured":"P\u00f6tter\u00a0R, Haie-Meder\u00a0C, Van Limbergen\u00a0E et\u00a0al (2006) Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy. Radiother Oncol 78(1):67\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2005.11.014","journal-title":"Radiother Oncol"},{"issue":"1","key":"2549_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijrobp.2008.10.033","volume":"75","author":"JCA Dimopoulos","year":"2009","unstructured":"Dimopoulos\u00a0JCA, Lang\u00a0S, Kirisits\u00a0C et\u00a0al (2009) Dose\u2013response relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Int J Radiat Oncol Biol Phys 75(1):56\u201363. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2549_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.radonc.2018.05.002","volume":"128","author":"R P\u00f6tter","year":"2018","unstructured":"P\u00f6tter\u00a0R, Tanderup\u00a0K, Schmid\u00a0MP et\u00a0al (2018) MRI-guided adaptive brachytherapy in gynecological cancers: a\u00a0paradigm shift toward personalized treatment. Radiother Oncol 128(3):345\u2013353. https:\/\/doi.org\/10.1016\/j.radonc.2018.05.002","journal-title":"Radiother Oncol"},{"issue":"5","key":"2549_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.brachy.2017.05.004","volume":"16","author":"C Onal","year":"2017","unstructured":"Onal\u00a0C, Kose\u00a0F, Oymak\u00a0E et\u00a0al (2017) The impact of center experience on outcomes of image-guided brachytherapy for gynecological cancers. Brachytherapy 16(5):1090\u20131098. https:\/\/doi.org\/10.1016\/j.brachy.2017.05.004","journal-title":"Brachytherapy"},{"key":"2549_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page\u00a0MJ, McKenzie\u00a0JE, Bossuyt\u00a0PM et\u00a0al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"10","key":"2549_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1471-0528.1988.tb06500.x","volume":"95","author":"CB Woodman","year":"1988","unstructured":"Woodman\u00a0CB, Mould\u00a0JJ, Jordan\u00a0JA (1988) Radiotherapy in the management of vaginal intraepithelial neoplasia after hysterectomy. Br J Obstet Gynaecol 95(10):976\u2013979. https:\/\/doi.org\/10.1111\/j.1471-0528.1988.tb06500.x","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"2549_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/gyno.1996.4608","volume":"65","author":"C MacLeod","year":"1997","unstructured":"MacLeod\u00a0C, Fowler\u00a0A, Dalrymple\u00a0C, Atkinson\u00a0K, Elliott\u00a0P, Carter\u00a0J (1997) High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. Gynecol Oncol 65(1):74\u201377. https:\/\/doi.org\/10.1006\/gyno.1996.4608","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2549_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0360-3016(97)00924-3","volume":"40","author":"I Ogino","year":"1998","unstructured":"Ogino\u00a0I, Kitamura\u00a0T, Okajima\u00a0H, Matsubara\u00a0S (1998) High-dose-rate intracavitary brachytherapy in the management of cervical and vaginal intraepithelial neoplasia. Int J Radiat Oncol Biol Phys 40(4):881\u2013887. https:\/\/doi.org\/10.1016\/S0360-3016(97)00924-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2549_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1067\/mob.2002.123202","volume":"187","author":"Y Teruya","year":"2002","unstructured":"Teruya\u00a0Y, Sakumoto\u00a0K, Moromizato\u00a0H et\u00a0al (2002) High dose-rate intracavitary brachytherapy for carcinoma in situ of the vagina occurring after hysterectomy: a rational prescription of radiation dose. Am J Obstet Gynecol 187(2):360\u2013364. https:\/\/doi.org\/10.1067\/mob.2002.123202","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2549_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ygyno.2007.03.005","volume":"106","author":"K Graham","year":"2007","unstructured":"Graham\u00a0K, Wright\u00a0K, Cadwallader\u00a0B, Reed\u00a0NS, Symonds\u00a0RP (2007) 20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3. Gynecol Oncol 106(1):105\u2013111. https:\/\/doi.org\/10.1016\/j.ygyno.2007.03.005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2549_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1634\/theoncologist.2010-0326","volume":"16","author":"P Blanchard","year":"2011","unstructured":"Blanchard\u00a0P, Monnier\u00a0L, Dumas\u00a0I, Morice\u00a0P, Pautier\u00a0P, Duvillard\u00a0P et\u00a0al (2011) Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia. Oncologist 16(2):182\u2013188. https:\/\/doi.org\/10.1634\/theoncologist.2010-0326","journal-title":"Oncologist"},{"issue":"1","key":"2549_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4143\/crt.2014.46.1.74","volume":"46","author":"JH Song","year":"2014","unstructured":"Song\u00a0JH, Lee\u00a0JH, Lee\u00a0JH, Park\u00a0JS, Hong\u00a0SH, Jang\u00a0HS et\u00a0al (2014) High-dose-rate brachytherapy for the treatment of vaginal intraepithelial neoplasia. Cancer Res Treat 46(1):74\u201380. https:\/\/doi.org\/10.4143\/crt.2014.46.1.74","journal-title":"Cancer Res Treat"},{"key":"2549_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejogrb.2015.08.018","volume":"194","author":"A Zolciak-\u015awi\u0144ska","year":"2015","unstructured":"Zolciak-\u015awi\u0144ska\u00a0A, Gruszczy\u0144ska\u00a0E, Jonska-Gmyrek\u00a0J, Kulik\u00a0A, Michalski\u00a0W (2015) Brachytherapy for vaginal intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol 194:73\u201377. https:\/\/doi.org\/10.1016\/j.ejogrb.2015.08.018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"2549_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14080838","volume":"14","author":"N F","year":"2024","unstructured":"F\u00a0N, R\u00a0A, Y\u00a0Z et\u00a0al (2024) Impact of Vaginal Dilator Use and 68\u202fGy EQD2(\u03b1\/\u03b2=3) Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer. J\u00a0Pers Med 14(8):838. https:\/\/doi.org\/10.3390\/jpm14080838","journal-title":"J Pers Med"},{"issue":"6","key":"2549_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s12094-023-03099-4","volume":"25","author":"Y Zhang","year":"2023","unstructured":"Zhang\u00a0Y, Noorian\u00a0F, Abellana\u00a0R et\u00a0al (2023) Vaginal dilator use more than 9\u00a0months is a\u00a0main prognostic factor for reducing G2-late vaginal complications in 3D-vaginal-cuff brachytherapy (interventional radiotherapy)? Clin Transl Oncol 25(6):1748\u20131755. https:\/\/doi.org\/10.1007\/s12094-023-03099-4","journal-title":"Clin Transl Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02549-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02549-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02549-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:20:14Z","timestamp":1787739614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02549-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02549-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.\u00a0Lancellotta, A.P.\u00a0Solazzo, B.\u00a0Fionda, G.\u00a0Garganese, S.M.\u00a0Fragomeni, A.\u00a0Federico, M.C.\u00a0LaMilia, P.\u00a0Dragonetti, E.\u00a0Rosa, L.\u00a0Bannoni, M.\u00a0DeAngeli, S.\u00a0Russi, S.\u00a0Laurino, A.G.\u00a0Morganti, R.P.\u00a0DeVincenzo, G.\u00a0Macchia, M.A.\u00a0Gambacorta, R.\u00a0Iezzi, and L.\u00a0Tagliaferri declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were waived for this study due to its retrospective nature. This study was performed within the framework of the Consortium for Brachytherapy Data Analysis initiative, following its standardized guidelines.","order":3,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}